University of Pittsburgh, School of Medicine, Pittsburgh, PA.
University of Michigan Medical Center, Department of Urology, Ann Arbor, MI.
Urology. 2022 Jul;165:331-335. doi: 10.1016/j.urology.2022.01.041. Epub 2022 Feb 12.
To examine the use of Direct Visual Internal Urethrotomy with Mitomycin-C (DVIU-MMC) for bladder neck contracture and vesicourethral anastomotic stenosis in men who have undergone treatment for prostate cancer with radical prostatectomy and/or radiation therapy.
Retrospective chart review of patients at a tertiary care center who underwent DVIU-MMC for recurrent bladder neck contracture/vesicourethral anastomotic stenosis between 2012 and 2020. Patients with complete urethral obliteration, prior bladder neck reconstruction, or less than 3 months of follow-up were excluded. Patients were sorted into three groups based on prostate cancer treatment history: radical prostatectomy (RP), RP with subsequent external beam radiation therapy (RP-EBRT), and radiation therapy (RT).
Fifty-one patients with a median follow up of 32 months were included. Twenty-nine percent had pre-operative suprapubic tube (SPT), Foley, or required clean intermittent catheterization. Overall success after initial DVIU-MMC was 45%. In all patients with up to four procedures, cumulative overall success was 84%. There was no significant difference in relative success rates between groups. However, the interval to recurrence after initial DVIU-MMC was shortest for RP-EBRT group (P = .018). Three patients required SPT, all were in the RP-EBRT group. There was no statistical difference in recurrence after any number of procedures between patients in radiation (RP-EBRT and RT) and non-radiation (RP) groups.
There was no significant difference in success rates between patients who had undergone RP-EBRT, RT, or RP. However, our data suggests that RP-EBRT patients experience poorer outcomes given that their interval to recurrence was more rapid and all patients requiring SPT placement were in this group.
探讨直接直视下尿道内切开术联合丝裂霉素 C(DVIU-MMC)治疗前列腺癌根治术和/或放疗后男性膀胱颈挛缩和膀胱颈-尿道吻合口狭窄的效果。
对 2012 年至 2020 年间在一家三级医疗中心接受 DVIU-MMC 治疗复发性膀胱颈挛缩/膀胱颈-尿道吻合口狭窄的患者进行回顾性图表分析。排除完全性尿道闭锁、先前膀胱颈重建或随访时间少于 3 个月的患者。根据前列腺癌治疗史将患者分为三组:前列腺癌根治术(RP)、RP 后行外照射放疗(RP-EBRT)和放疗(RT)。
共纳入 51 例患者,中位随访时间为 32 个月。29%的患者术前留置耻骨上导尿管(SPT)、 Foley 导尿管或需要间歇性清洁导尿。初次 DVIU-MMC 后的总体成功率为 45%。所有接受 4 次以内手术的患者,累积总体成功率为 84%。各组间相对成功率无显著差异。但 RP-EBRT 组初次 DVIU-MMC 后复发的时间间隔最短(P=0.018)。3 例患者需要 SPT,均为 RP-EBRT 组。无论进行多少次手术,放疗(RP-EBRT 和 RT)和非放疗(RP)组的患者复发率均无统计学差异。
RP-EBRT、RT 和 RP 组的患者成功率无显著差异。然而,我们的数据表明,RP-EBRT 组患者的预后较差,因为他们的复发时间间隔更短,而且所有需要 SPT 置管的患者均来自该组。